Cuba approves second homegrown covid vaccine for late phase trials

The Cuban regulatory authority gave the green light for it to start late-stage clinical trials for Abdala, which like Soberana 2 targets the spike protein of the novel coronavirus

from mint - News https://ift.tt/3r2EsDx
https://ift.tt/eA8V8J